Sachio Shibata

542 total citations
14 papers, 312 citations indexed

About

Sachio Shibata is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Sachio Shibata has authored 14 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Sachio Shibata's work include Hedgehog Signaling Pathway Studies (5 papers), Epigenetics and DNA Methylation (5 papers) and Sphingolipid Metabolism and Signaling (3 papers). Sachio Shibata is often cited by papers focused on Hedgehog Signaling Pathway Studies (5 papers), Epigenetics and DNA Methylation (5 papers) and Sphingolipid Metabolism and Signaling (3 papers). Sachio Shibata collaborates with scholars based in Japan and United States. Sachio Shibata's co-authors include Hideaki Tojo, Maki Miyamoto, Shigeru Kondo, Yuya Oguro, Yukiko Yamamoto, Toshio Tanaka, Atsuo Baba, Tomohiro Kawamoto, Zenyu Shiokawa and Satoshi Sasaki and has published in prestigious journals such as Cancer Research, Scientific Reports and The FASEB Journal.

In The Last Decade

Sachio Shibata

14 papers receiving 303 citations

Peers

Countries citing papers authored by Sachio Shibata

Since Specialization

Citations

This map shows the geographic impact of Sachio Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachio Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachio Shibata more than expected).

Fields of papers citing papers by Sachio Shibata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachio Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachio Shibata. The network helps show where Sachio Shibata may publish in the future.

Co-authorship network of co-authors of Sachio Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Sachio Shibata. A scholar is included among the top collaborators of Sachio Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachio Shibata. Sachio Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Identification of the first highly selective inhibitor of human lactate dehydrogenase B 2021 ·Scientific Reports ·Sachio Shibata, Satoshi Sogabe, Masanori Miwa, Takuya Fujimoto, Nobuyuki Takakura, (unknown), Shuji Kitamura, Tomohiro Kawamoto, Tomoyoshi Soga	37
2	A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease 2021 ·Journal of Neurochemistry ·Takahiro Fujii, Yuta Tanaka, Hideyuki Oki, Sho Sato, Sachio Shibata, (unknown), Maiko Tanaka, Tomohiro Onishi	14
3	Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate‐salt hypertensive uni‐nephrectomized KKA ^y mice 2020 ·The FASEB Journal ·Yasunori Nio, (unknown), (unknown), Guido Hanauer, Kimio Tohyama, Sachio Shibata, Tomoya Sano, (unknown), Hisashi Anayama, Masatoshi Hazama, Takanori Matsuo	5
4	Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension 2019 ·Bioscience Biotechnology and Biochemistry ·Yo Muraki, (unknown), Kimio Tohyama, Sachio Shibata, (unknown), Yasunori Nio, Masatoshi Hazama, Takanori Matsuo	9
5	CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens 2017 ·Scientific Reports ·Tsuyoshi Ishii, (unknown), (unknown), Manabu Mochizuki, (unknown), Masako Kuno, Masato Yoshikawa, Sachio Shibata, Masanori Nakakariya, Takatoshi Yogo, Tomohiro Kawamoto	38
6	Antitumor activity of a novel and orally available inhibitor of serine palmitoyltransferase 2017 ·Biochemical and Biophysical Research Communications ·(unknown), Sachio Shibata, Yoshinori Satomi, Megumi Hirayama, Ryutaro Adachi, Yasutomi Asano, (unknown), Yasuhiro Hirata, Akio Mizutani, Atsushi Kiba, Yoji Sagiya	16
7	Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1H)-one Derivatives as Orally eIF4A3-Selective Inhibitors 2017 ·ACS Medicinal Chemistry Letters ·Ryo Mizojiri, Daisuke Nakata, Yoshihiko Satoh, Daisuke Morishita, Sachio Shibata, (unknown), Yohei Kosugi, (unknown), (unknown), Shigekazu Sasaki, Kazuaki Takami, (unknown), Masahiro Kamaura, Shinobu Sasaki, (unknown), Douglas R. Cary, Yasuhiro Imaeda	11
8	Synthesis and evaluation of hedgehog signaling inhibitor with novel core system 2015 ·Bioorganic & Medicinal Chemistry ·Tomohiro Ohashi, Yuta Tanaka, Zenyu Shiokawa, Hiroshi Banno, Toshio Tanaka, Sachio Shibata, Yoshihiko Satoh, (unknown), Yukiko Yamamoto, (unknown), Shigeru Kondo, Maki Miyamoto, Hideaki Tojo, Atsuo Baba, Satoshi Sasaki	4
9	Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice 2013 ·Drug Metabolism and Disposition ·Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga R. Prakash, Wen Chyi Shyu, Satoru Asahi	15
10	Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors 2012 ·Bioorganic & Medicinal Chemistry ·Tomohiro Ohashi, Yuya Oguro, Toshio Tanaka, Zenyu Shiokawa, Sachio Shibata, Yoshihiko Sato, (unknown), (unknown), Yukiko Yamamoto, Shigeru Kondo, Maki Miyamoto, Hideaki Tojo, Atsuo Baba, Satoshi Sasaki	55
11	Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: Modification of the core skeleton for improved solubility 2012 ·Bioorganic & Medicinal Chemistry ·Tomohiro Ohashi, Yuya Oguro, Toshio Tanaka, Zenyu Shiokawa, Yuta Tanaka, Sachio Shibata, Yoshihiko Sato, (unknown), (unknown), Yukiko Yamamoto, Shigeru Kondo, Maki Miyamoto, Mitsuhiro Nishihara, (unknown), Hideaki Tojo, Atsuo Baba, Satoshi Sasaki	60
12	Abstract 2823: TAK-441, a novel investigational small molecule hedgehog pathway inhibitor for use in cancer therapy 2011 ·Cancer Research ·Hideaki Tojo, Sachio Shibata, Yoshihiko Satoh, Mihoko Kawamura, Masakazu Inazuka, (unknown), Masahide Kashiwagi, Maki Miyamoto, Shigeru Kondo, (unknown), Yuya Oguro, Satoshi Sasaki	2
13	Loss of lysophospholipase 3 increases atherosclerosis in apolipoprotein E-deficient mice 2005 ·Biochemical and Biophysical Research Communications ·Yoshio Taniyama, Hiromitsu Fuse, (unknown), Ryuichi Tozawa, Yoshitaka Yasuhara, (unknown), Sachio Shibata, Masahiko Hattori, Mitsugu Nakata, Shigehisa Taketomi	13
14	Cloning and Expression of a Novel Lysophospholipase Which Structurally Resembles Lecithin Cholesterol Acyltransferase 1999 ·Biochemical and Biophysical Research Communications ·Yoshio Taniyama, Sachio Shibata, Shunbun Kita, (unknown), Hiromitsu Fuse, Hideo Shirafuji, Yasuhiro Sumino, Masahiko Fujino	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact